ISOFLAVONOID LEVELS IN SPOT URINE ARE ASSOCIATED WITH FREQUENCY OF DIETARY SOY INTAKE IN A POPULATION-BASED SAMPLE OF MIDDLE-AGED AND OLDERCHINESE IN SINGAPORE
A. Seow et al., ISOFLAVONOID LEVELS IN SPOT URINE ARE ASSOCIATED WITH FREQUENCY OF DIETARY SOY INTAKE IN A POPULATION-BASED SAMPLE OF MIDDLE-AGED AND OLDERCHINESE IN SINGAPORE, Cancer epidemiology, biomarkers & prevention, 7(2), 1998, pp. 135-140
Soy products contain high amounts of isoflavonoids, which have been sh
own to exhibit possible cancer-protective properties. Chinese populati
ons in Asia, in particular, have a high level of soy intake and a rela
tively low risk of hormone-dependent cancers. In this study, we assess
ed the distributions of dietary soy isoflavonoids (daidzein, genistein
, and glycitein) and urinary soy isoflavonoids and their metabolites (
daidzein, genistein, glycitein, equol, and O-desmethylangolensin) amon
g 147 Singapore Chinese (76 men and 71 women) ages 45-74 years, who ar
e participants of the Singapore Cohort Study on diet and cancer. Urina
ry values were measured from spot samples collected 10-20 months follo
wing recruitment, when usual dietary habits were assessed by a structu
red food frequency/portion size questionnaire administered in person.
Dietary levels of daidzein and genistein were comparable within indivi
duals and about seven times higher than the level of dietary glycitein
. All three dietary isoflavonoids showed an approximately 3.5-fold dif
ference between the 25th and 75th percentile values. Similarly, daidze
in was the most abundant and glycitein the least abundant of the five
isoflavonoid compounds in urine. There was a 4.9-fold difference betwe
en the 25th and 75th percentile values for the sum of the five urinary
isoflavonoids. Among study subjects, there were statistically signifi
cant, dose-dependent associations between frequency of overall soy int
ake and levels of urinary daidzein (two-sided P = 0.03) and sum of uri
nary daidzein, genistein, and glycitein (two-sided P = 0.04). In contr
ast, there were no associations between frequency of overall soy intak
e and levels of the two daidzein metabolites (equol and O-desmethylang
olensin) in urine (two-sided P = 0.85 and 0.34, respectively). We sugg
est that within the range of exposures experienced by Singapore Chines
e, urinary level of daidzein or the sum of daidzein, genistein, and gl
ycitein obtained from a spot sample can serve as a biomarker of curren
t soy consumption in epidemiological studies of diet-disease associati
ons.